1. Baba S, Yamanaka N, Suzuki K, et al. Clinical efficacy, safety and PK-PD analysis of Tebipenem pivoxil in a phase II clinical trial in otolaryngological infections. Jpn J Antibiot. 2009;62(2):155.
2. Kataoka H, Kasahara H, Sasagawa Y, Matsumoto M, Shimada S. Evaluation of safety and efficacy of tebipenem pivoxil granules for pediatric in pneumonia, otitis media and sinusitis. Jpn J Antibiot. 2016;69(1):53–76.
3. Jain A, Utley L, Parr TR, Zabawa T, Pucci MJ. Tebipenem, the first oral carbapenem antibiotic. Expert Rev Anti Infect Ther. 2018;16(7):513–22.
4. Sugano T, Yamada K, Baba N, et al. Mechanism for tebipenem antimicrobial activity against Streptococcus pneumoniae and Haemophilus influenzae. Jpn J Chemother. 2009;57:15–29.
5. Chao T, Li C, Liu S, et al. Crystal structure of tebipenem pivoxil. Acta Crystallogr A. 2018;74(9):1215–7.